Search icon
TCS, HDFCBANK, SBI Liquid Fund (G)
Dr. Lal Pathlabs Ltd.

Dr. Lal Pathlabs

NSE

₹ 0.00

0.00 (0.00)%

Healthcare

Small-cap

With a market cap of ₹18.90L Cr.

Moderate Volatility
Stock is 1.13x as volatile as index
To access realtime data for Reliance Industries Ltd, and use advance features for trading Register or Login to Orca.
EX-DatePurpose
21 05 2021 Audited Results & Final Dividend
30 07 2021 Interim Dividend & Quarterly Results
26 10 2021 Quarterly Results
10 02 2022 Quarterly Results
17 05 2022 Audited Results & Final Dividend
28 07 2022 Quarterly Results & Interim Dividend
08 11 2022 Quarterly Results
02 02 2023 Quarterly Results
11 05 2023 Final Dividend & Audited Results
27 07 2023 Quarterly Results & Interim Dividend
02 11 2023 Quarterly Results
01 02 2024 Quarterly Results & Interim Dividend
23 10 2024 Quarterly Results & Interim Dividend
30 01 2025 Quarterly Results & Interim Dividend
25 04 2025 Audited Results & Final Dividend

News

11-MAY-2023

Dr. Lal Pathlabs reports 8% fall in Q4 consolidated net profit

Total consolidated income of the company increased by 1.55% at Rs 505.20 crore for Q4FY23

04:51 PM
15-APR-2025

Dr. Lal PathLabs launches test for Amyloidosis disease

With this launch, the company becomes the first diagnostic chain in South Asia to offer this highly specialized test

12:21 PM
15-MAR-2023

Dr. Lal PathLabs selects Kyndryl to manage IT infrastructure stack

Post onboarding, Kyndryl has been instrumental in managing the multiple cloud platforms

03:08 PM
31-JAN-2023

Dr. Lal Pathlabs’ arm gets nod to acquire further 10% stake in APRL PathLabs

The Board of Directors of the company in their meeting held on January 30, 2023 approved the same

10:00 AM
Enrich money logo